JAK Inhibitors

Overview of Myelofibrosis Treatment and Research

by
Overview of Myelofibrosis Treatment and Research

Compiled by: Moonlit LotusSource: Oncology Information Currently, JAK inhibitors (JAKi) are the most effective treatment options for myelofibrosis (MF), and research targeting other molecular pathways is actively ongoing. This article briefly introduces the diagnosis and outcomes of MF, focusing on existing treatments and ongoing research. It is evident that there is significant potential for the … Read more

Immunomodulatory ADCs: A New Weapon Against Autoimmune Diseases

by
Immunomodulatory ADCs: A New Weapon Against Autoimmune Diseases

▎This article is contributed by Ying’en Biotech (slightly edited) Since the first antibody-drug conjugate (ADC) was approved for the treatment of acute myeloid leukemia in 2000, after more than twenty years of exploration and development, 14 ADC drugs have been successfully approved for clinical treatment of tumors. In August 2022, the FDA announced the accelerated … Read more